Probabilistic Multiple-Bias Analyses of Observational Studies on Narcolepsy Following Vaccination with GlaxoSmithKline's Inactivated Adjuvanted (AS03) A/H1N1pdm09 Pandemic Influenza Vaccine

被引：0
|
作者：
Bollaerts, Kaatje [1 ]
Shinde, Vivek [2 ]
Dos Santos, Gael [3 ]
Ferreira, Germano [4 ]
Bauchau, Vincent [4 ]
Cohet, Catherine [4 ]
Verstraeten, Thomas [1 ]
机构：
[1] P95 Pharmacovigilance & Epidemiol, Leuven, Belgium
[2] GlaxoSmith Kline Vaccines, Philadelphia, PA USA
[3] Business & Decis Life Sci, Brussels, Belgium
[4] Glaxo SmithKline Vaccines, Wavre, Belgium
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
5
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [31] Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials
    Vaughn, David W.
    Seifert, Harry
    Hepburn, Anne
    Dewe, Walthere
    Li, Ping
    Drame, Mamadou
    Cohet, Catherine
    Innis, Bruce L.
    Fries, Louis F.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (10) : 2942 - 2957
  • [32] Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series
    Cohet, Catherine
    Haguinet, Francois
    Dos Santos, Gael
    Webb, Dave
    Logie, John
    Ferreira, Germano Lc
    Rosillon, Dominique
    Shinde, Vivek
    BMJ OPEN, 2016, 6 (01):
  • [33] Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant
    Ferguson, Murdo
    Risi, George
    Davis, Matthew
    Sheldon, Eric
    Baron, Mira
    Li, Ping
    Madariaga, Miguel
    Fries, Louis
    Godeaux, Olivier
    Vaughn, David
    JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (05): : 733 - 744
  • [34] Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine Two Open-label, Randomized Trials
    Vesikari, Timo
    Richardus, Jan Hendrik
    Berglund, Johan
    Korhonen, Tiina
    Flodmark, Carl-Erik
    Lindstrand, Ann
    Silfverdal, Sven Arne
    Bambure, Vinod
    Caplanusi, Adrian
    Dieussaert, Ilse
    Roy-Ghanta, Sumita
    Vaughn, David W.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (07) : 774 - 782
  • [35] Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies
    Garcia-Sicilia, Jose
    Aristegui, Javier
    Omenaca, Felix
    Carmona, Alfonso
    Tejedor, Juan C.
    Merino, Jose M.
    Garcia-Corbeira, Pilar
    Walravens, Karl
    Bambure, Vinod
    Moris, Philippe
    Caplanusi, Adrian
    Gillard, Paul
    Dieussaert, Ilse
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (10) : 2359 - 2369
  • [36] Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial
    Yang, William H.
    Dionne, Marc
    Kyle, Michael
    Aggarwal, Naresh
    Li, Ping
    Madariaga, Miguel
    Godeaux, Olivier
    Vaughn, David W.
    VACCINE, 2013, 31 (40) : 4389 - 4397
  • [37] Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine
    Sato, Kayoko
    Takahashi, Yoshimasa
    Adachi, Yu
    Asanuma, Hideki
    Ato, Manabu
    Tashiro, Masato
    Itamura, Shigeyuki
    HELIYON, 2019, 5 (01)
  • [38] Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada? A review of post-marketing safety surveillance data
    Harris, T.
    Wong, K.
    Stanford, L.
    Fediurek, J.
    Crowcroft, N.
    Deeks, S. L.
    EUROSURVEILLANCE, 2014, 19 (36): : 18 - 22
  • [39] Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
    Trieu, Mai-Chi
    Zhou, Fan
    Lartey, Sarah Larteley
    Sridhar, Saranya
    Mjaaland, Siri
    Cox, Rebecca Jane
    NPJ VACCINES, 2018, 3
  • [40] Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
    Mai-Chi Trieu
    Fan Zhou
    Sarah Larteley Lartey
    Saranya Sridhar
    Siri Mjaaland
    Rebecca Jane Cox
    npj Vaccines, 3
12345